Usana Health Sciences (USNA) EPS (Basic) (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of EPS (Basic) data on file, last reported at $0.38 in Q2 2026.

• On a quarterly basis, EPS (Basic) fell 22.44% year-over-year to $0.38 in Q2 2026; TTM through Apr 2026 was $0.5, a 72.8% decrease from a year earlier, with the FY2026 full-year figure at $0.62, down 71.88% from the prior year.
• EPS (Basic) for Q2 2026 stood at $0.38, up from -$0.09 in the prior quarter.
• Over the last five years, EPS (Basic) for USNA reached as high as $1.16 in Q2 2022 and fell as low as -$0.36 in Q3 2025.
• Historically, EPS (Basic) has averaged $0.62 across 5 years, with a median of $0.63 in 2023.
• Across the five-year window, EPS (Basic) surged 31.06% in 2023 and plunged 165.5% in 2025, its largest moves.
• Year by year, EPS (Basic) stood at $0.66 in 2022, then jumped by 31.06% to $0.87 in 2023, then slumped by 73.05% to $0.23 in 2024, then plunged by 255.15% to -$0.36 in 2025, then soared by 203.86% to $0.38 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $0.38 in Q2 2026, -$0.09 in Q1 2026, and -$0.36 in Q3 2025.